Martin R Berger

Title: Martin R Berger: Innovator in Tumor Treatment

Introduction

Martin R Berger is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of oncology, particularly in the treatment of tumors and their metastases. With a total of 2 patents, his work focuses on innovative therapeutic methods that target specific biological markers.

Latest Patents

Berger's latest patents include a method for treating tumors and their metastases. This invention relates to a therapy designed for tumors that preferentially settle in bone tissue. The method involves administering an active ingredient that comprises at least one binding molecule that binds to human bone sialoprotein or a fragment thereof. Another significant patent is a medicament for treating tumors and their metastases, which also targets bone tissue. This medicament includes at least one binding molecule that binds to bone sialoprotein or a fragment thereof in serum or plasma.

Career Highlights

Martin R Berger is associated with Armbruster Biotechnology GmbH, where he continues to develop innovative solutions for cancer treatment. His work is characterized by a strong focus on the biological mechanisms of tumor growth and metastasis.

Collaborations

Some of his notable coworkers include Franz Paul Armbruster and Markus Karmatschek. Their collaborative efforts contribute to the advancement of research in biotechnology and oncology.

Conclusion

Martin R Berger's contributions to the field of tumor treatment exemplify the impact of innovative thinking in medicine. His patents reflect a commitment to improving therapeutic options for patients facing challenging diagnoses.